nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Commentary on “Comprehensive Review of Sentinel Lymphadenectomy in Breast Cancer”
|
Reintgen, Douglas |
|
2000 |
1 |
2 |
p. 126- 1 p. |
artikel |
2 |
Commentary on “Internet Usage Among Women with Breast Cancer: An Exploratory Study”
|
Burstein, Harold J. |
|
2000 |
1 |
2 |
p. 154-155 2 p. |
artikel |
3 |
Commentary on “Paclitaxel, 5-Fluorouracil, and Leucovorin (TFL) in the Treatment of Metastatic Breast Cancer”
|
Seidman, Andrew |
|
2000 |
1 |
2 |
p. 144- 1 p. |
artikel |
4 |
Commentary on “Prophylactic Surgery for Women at High Risk for Breast Cancer”
|
Garber, Judy |
|
2000 |
1 |
2 |
p. 135- 1 p. |
artikel |
5 |
Commentary on “Role of 2-[18F]-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) in the Early Assessment of Response to Chemotherapy in Metastatic Breast Cancer Patients”
|
Rosen, Eric |
|
2000 |
1 |
2 |
p. 162-163 2 p. |
artikel |
6 |
Comprehensive Review of Sentinel Lymphadenectomy in Breast Cancer
|
Kelemen, Pond R. |
|
2000 |
1 |
2 |
p. 111-125 15 p. |
artikel |
7 |
Docetaxel in Combination with Epirubicin as Neoadjuvant Therapy in Operable Breast Cancer
|
|
|
2000 |
1 |
2 |
p. 107-108 2 p. |
artikel |
8 |
HER2 Gene Amplification by Fluorescence In Situ Hybridization(FISH) as a Predictor of Response to Trastuzumab in Metastatic Breast Cancer
|
|
|
2000 |
1 |
2 |
p. 105-106 2 p. |
artikel |
9 |
2000 Highlights from: 36th Annual ASCO Meeting; New Orleans, LA May, 2000
|
|
|
2000 |
1 |
2 |
p. 96-102 7 p. |
artikel |
10 |
Internet Usage Among Women with Breast Cancer: An Exploratory Study
|
Pereira, Jose L. |
|
2000 |
1 |
2 |
p. 148-153 6 p. |
artikel |
11 |
Letter to the Editor
|
Patridge, Ann |
|
2000 |
1 |
2 |
p. 164-165 2 p. |
artikel |
12 |
Paclitaxel, 5-Fluorouracil, and Leucovorin (TFL) in the Treatment of Metastatic BreastCancer
|
Nicholson, Brenda P. |
|
2000 |
1 |
2 |
p. 136-143 8 p. |
artikel |
13 |
Prophylactic Surgery for Women at High Risk for Breast Cancer
|
Blanchard, Kay D. |
|
2000 |
1 |
2 |
p. 127-134 8 p. |
artikel |
14 |
Role of 2-[18F]-Fluorodeoxyglucose (FDG) Positron Emission Tomography (PET) in the Early Assessment of Response to Chemotherapy in Metastatic Breast Cancer Patients
|
Gennari, Alessandra |
|
2000 |
1 |
2 |
p. 156-161 6 p. |
artikel |
15 |
The EORTC Strategy for the Early 2000's
|
Piccart, M.J. |
|
2000 |
1 |
2 |
p. 166-167 2 p. |
artikel |
16 |
The Future of Clinical Research in Breast Cancer: Opportunities
|
Sledge Jr., George W. |
|
2000 |
1 |
2 |
p. 95- 1 p. |
artikel |
17 |
Trastuzumab as First-Line Therapy of Metastatic Breast Cancer
|
|
|
2000 |
1 |
2 |
p. 103-104 2 p. |
artikel |